Mechanistic Basis for Intradialytic Hypertension with Hemodialysis
- PMID: 38265791
- PMCID: PMC10937007
- DOI: 10.2215/CJN.0000000000000408
Mechanistic Basis for Intradialytic Hypertension with Hemodialysis
Conflict of interest statement
M. Hecking reports employment with Kuratorium for Dialysis and Transplantation Germany; research funding from Astellas Pharma, Boehringer Ingelheim, Eli Lilly, and Siemens Healthcare; and honoraria from Bayer AG, Fresenius Medical Care, Janssen-Cilag, and Vifor. M. Hecking has served as a speaker and/or consultant for Astellas Pharma, AstraZeneca, Eli Lilly, Fresenius Medical Care, Janssen-Cilag, Siemens Healthcare, and Vifor and has previously received academic study support from Astellas Pharma, Boehringer Ingelheim, Eli Lilly, Nikkiso, and Siemens Healthcare (not related to the present work). All remaining authors have nothing to disclose.
Figures

Comment on
-
Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis.Clin J Am Soc Nephrol. 2024 Mar 1;19(3):329-335. doi: 10.2215/CJN.0000000000000356. Epub 2023 Nov 16. Clin J Am Soc Nephrol. 2024. PMID: 37971865 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical